GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ardalan, Kaveh  (3)
  • 1
    Online Resource
    Online Resource
    Wiley ; 2017
    In:  Arthritis Care & Research Vol. 69, No. 9 ( 2017-09), p. 1391-1399
    In: Arthritis Care & Research, Wiley, Vol. 69, No. 9 ( 2017-09), p. 1391-1399
    Abstract: To determine the prevalence and risk factors for hospitalization with dermatomyositis and assess inpatient burden of dermatomyositis. Methods Data on 72,651,487 hospitalizations from the 2002–2012 Nationwide Inpatient Sample, a 20% stratified sample of all acute‐care hospitalizations in the US, were analyzed. International Classification of Diseases, Ninth Revision, Clinical Modification coding was used to identify hospitalizations with a diagnosis of dermatomyositis. Results There were 9,687 and 43,188 weighted admissions with a primary or secondary diagnosis of dermatomyositis, respectively. In multivariable logistic regression models with stepwise selection, female sex (logistic regression: adjusted odds ratio 2.05 [95% confidence interval (95% CI) 1.80, 2.34]), nonwhite race (African American: 1.68 [1.57, 1.79] ; Hispanic: 2.38 [2.22, 2.55]; Asian: 1.54 [1.32, 1.81] ; and multiracial/other: 1.65 [1.45, 1.88]), and multiple chronic conditions (2–5: 2.39 [2.20, 2.60] and ≥6: 2.80 [2.56, 3.07]) were all associated with higher rates of hospitalization for dermatomyositis. The weighted total length of stay (LOS) and inflation‐adjusted cost of care for patients with a primary inpatient diagnosis of dermatomyositis was 80,686 days and $168,076,970, with geometric means of 5.38 (95% CI 5.08, 5.71) and $11,682 (95% CI $11,013, $12,392), respectively. LOS and costs of hospitalization were significantly higher in patients with dermatomyositis compared to those without. Notably, race/ethnicity was associated with increased LOS (log‐linear regression: adjusted β [95% CI] for African American: 0.14 [0.04, 0.25] and Asian: 0.38 [0.22, 0.55] ) and cost of care (Asian: 0.51 [0.36, 0.67] ). Conclusion There is a significant and increasing inpatient burden for dermatomyositis in the US. There appear to be racial differences, as nonwhites have higher prevalence of admission, increased LOS, and cost of care.
    Type of Medium: Online Resource
    ISSN: 2151-464X , 2151-4658
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2016713-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Arthritis Care & Research, Wiley, Vol. 69, No. 5 ( 2017-05), p. 753-757
    Abstract: To assess the validity of using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) code 710.3 to identify adult patients with dermatomyositis in outpatient and inpatient settings. Methods Electronic medical records of adult patients with ICD‐9 code 710.3 between January 2001 and November 2014 (n = 511) were examined. Physician diagnosis, clinical findings, and diagnostic testing results were recorded. A dermatomyositis rating scale was assigned based on classic cutaneous findings and at least 2 additional clinical and diagnostic findings from the Bohan criteria. Sensitivity and positive predictive values (PPVs) were determined. Sensitivity analyses were performed to evaluate the accuracy of multiple ICD‐9 codes in the outpatient setting, as well as primary and secondary inpatient codes. Results The sensitivity and PPV for multiple 710.3 ICD‐9 codes in the outpatient setting were 0.89 and 0.35, respectively. The PPV for primary and secondary 710.3 inpatient codes was 0.95 and as high as 0.8. However, the sensitivity of ICD‐9 code 710.3 was poor in the inpatient setting (primary 0.23 and secondary 0.26). The most common reason for failure to meet appropriate dermatomyositis criteria was miscoding as diabetes mellitus (32%), followed by diagnosis at an outside institution (19%), dermatomyositis as a rule‐out diagnosis (10%), cutaneous dermatomyositis (8%), and juvenile dermatomyositis (6%). Conclusion One or more occurrences of ICD‐9 code 710.3 is insufficient to support the diagnosis of dermatomyositis in the outpatient setting. However, ICD‐9 710.3 codes appear to be valid in the inpatient setting.
    Type of Medium: Online Resource
    ISSN: 2151-464X , 2151-4658
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2016713-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Rheumatology, Oxford University Press (OUP), Vol. 57, No. 4 ( 2018-04-01), p. 694-702
    Type of Medium: Online Resource
    ISSN: 1462-0324 , 1462-0332
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2018
    detail.hit.zdb_id: 1474143-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...